StockNews.com Upgrades Aspen Aerogels (NYSE:ASPN) to Sell

Aspen Aerogels (NYSE:ASPN) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a note issued to investors on Saturday.

Other equities research analysts also recently issued research reports about the stock. Roth Mkm dropped their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Barclays lowered their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. HC Wainwright reiterated a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Finally, Piper Sandler cut their target price on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus target price of $29.11.

Aspen Aerogels Stock Down 1.2 %

Shares of NYSE:ASPN opened at $11.49 on Friday. The company has a market capitalization of $942.34 million, a price-to-earnings ratio of 1,149.65 and a beta of 2.14. The company has a 50 day moving average of $12.50 and a two-hundred day moving average of $18.83. Aspen Aerogels has a 52-week low of $10.67 and a 52-week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds have recently added to or reduced their stakes in ASPN. FMR LLC lifted its position in shares of Aspen Aerogels by 23.6% in the 3rd quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock worth $112,169,000 after buying an additional 773,647 shares during the last quarter. Loomis Sayles & Co. L P raised its stake in Aspen Aerogels by 22.7% during the third quarter. Loomis Sayles & Co. L P now owns 1,619,320 shares of the construction company’s stock worth $44,839,000 after acquiring an additional 300,076 shares during the period. State Street Corp lifted its holdings in Aspen Aerogels by 0.6% in the third quarter. State Street Corp now owns 1,410,543 shares of the construction company’s stock worth $39,058,000 after acquiring an additional 8,344 shares during the last quarter. Geode Capital Management LLC boosted its stake in Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after acquiring an additional 75,024 shares during the period. Finally, Rice Hall James & Associates LLC boosted its stake in Aspen Aerogels by 3.6% in the fourth quarter. Rice Hall James & Associates LLC now owns 554,202 shares of the construction company’s stock valued at $6,584,000 after acquiring an additional 19,089 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.